Literature DB >> 34429282

How many infants may have died in low-income and middle-income countries in 2020 due to the economic contraction accompanying the COVID-19 pandemic? Mortality projections based on forecasted declines in economic growth.

Gil Shapira1, Damien de Walque2, Jed Friedman2.   

Abstract

OBJECTIVES: While COVID-19 has a relatively small direct impact on infant mortality, the pandemic is expected to indirectly increase mortality of this vulnerable group in low-income and middle-income countries through its effects on the economy and health system performance. Previous studies projected indirect mortality by modelling how hypothesised disruptions in health services will affect health outcomes. We provide alternative projections, relying on modelling the relationship between aggregate income shocks and mortality.
DESIGN: We construct a sample of 5.2 million births by pooling retrospective birth histories reported by women in Demographic and Health Surveys conducted in 83 low-income and middle-income countries between 1985 and 2018. We employ regression models with country-specific fixed-effects and flexible time trends to estimate the impact of gross domestic product per capita on infant mortality rate. We then use growth projections by the International Monetary Fund to predict the effect of the economic downturn in 2020 on infant mortality.
RESULTS: We estimate 267 208 (95% CI 112 000 to 422 415) excess infant deaths in 128 countries, corresponding to a 6.8% (95% CI 2.8% to 10.7%) increase in the total number of infant deaths expected in 2020.
CONCLUSIONS: The findings underscore the vulnerability of infants to the negative income shocks such as those imposed by the COVID-19 pandemic. While efforts towards prevention and treatment of COVID-19 remain paramount, the global community should also strengthen social safety nets and assure continuity of essential health services. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  COVID-19; health economics; health policy

Mesh:

Year:  2021        PMID: 34429282      PMCID: PMC8413467          DOI: 10.1136/bmjopen-2021-050551

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   3.006


Our study links gross domestic product (GDP) per capita data to an especially large dataset of 5.2 million retrospective birth histories reported in Demographic and Health Surveys conducted in many low-income and middle-income countries between 1985 and 2018. While previous projections of indirect COVID-19 mortality have been based on assumptions regarding the magnitude of health service disruptions, our estimates account for additional mechanisms, mainly increased household poverty. Our estimates may represent a lower bound of the actual excess mortality if the current economic downturn is accompanied by larger disruptions to the provision of essential health services relative to previous downturns. We estimate the short-term impact of GDP fluctuations on mortality while long-term implications for mortality and other adverse outcomes may also arise. The analysis ascribes the difference between October 2019 and October 2020 economic growth projections for 2020 solely to the pandemic, even though some countries have also experienced other shocks, such as natural disasters or political crises that may affect national income levels.

Introduction

Reducing morality risk in the wake of the COVID-19 pandemic is a paramount public concern. While direct mortality risk as a result of COVID-19 infection has garnered the majority of attention in global media and policy discussions, indirect mortality may be substantial. Health and social policies should not lose sight of excess indirect mortality caused by such factors as the interruption of essential health services and the general economic downturn brought on by the pandemic. This study attempts to quantify the expected indirect mortality over the pandemic period for one especially vulnerable subpopulation—infants—by modelling the impact of projected economic decline on the likelihood of infant survival. Studies from diverse settings find negligible direct mortality rates for children and infants due to COVID-19.1 However, stringent containment measures and the ensuing economic downturn, as well as the need to reallocate health system resources towards pandemic response, have influenced many social determinants of mortality such as the ability to afford nutritious foods and to access essential healthcare. Unlike economic crises in high-income countries, which appear to lower mortality,2 economic crises in low-income countries generally increase mortality among vulnerable groups, namely young children and the elderly. Earlier studies have documented a robust relationship between short-term fluctuation in aggregate income and all-cause infant mortality in low-income and middle-income countries.3–8 At the very start of the COVID-19 pandemic, modelling exercises predicted that the interruption of essential health services will be severe9–1412 and perhaps the world will experience 250 000 to 1.15 million young child deaths15 in the first 6 months of the pandemic. Recent studies indicate that barriers to access essential healthcare in low-income and middle-income countries are not just a theoretical concern documenting, for example, disruptions in immunisation services in Pakistan and Sierra Leone16 17 and access to primary care in sub-Saharan Africa.18 19 At the same time, the global economy is expected to contract 4.9% in the first year of the pandemic20 and the global poverty headcount is projected to increase by 120 million people.21 Based on historical data, this economic decline is likely to be associated with higher mortality in excess of COVID-19 fatalities,22 especially in low-income and middle-income economies, and will create food insecurity23 and lower the affordability among vulnerable households of key goods and services necessary for child survival. In this study, we estimate the impact of the economic downturn on infant mortality by modelling the relationship between GDP fluctuations and infant mortality, following the approach of Baird et al.5 We link GDP per capita data to 5.2 million retrospective birth histories reported in 83 Demographic and Health Surveys (DHS) conducted in low-income and middle-income countries between 1985 and 2017. Then, we use growth projections by International Monetary Fund (IMF) World Economic Outlook (WEO) to predict the effect of the economic downturn in 2020 on infant mortality.

Data and methods

To estimate the impact of changes in aggregate income on infant mortality, we rely on two sources of data. Data on GDP per capita is taken from the World Development Indicators. We use values adjusted for purchasing power parity, corresponding to 2011 US dollars. Data on infant mortality are constructed from retrospective birth history reports in all DHS conducted in 83 low-income and middle-income countries between 1985 and 2018. The surveys used in the analysis are listed in online supplemental appendix table A1. The combined sample totals 5.2 million births, of which 27% and 55% are from low-income and lower-middle-income countries. Over the full period of analysis, the sample’s infant mortality rate per 1000 births is 85, 61 and 37 for low-income, lower-middle-income and upper-middle-income countries, respectively. We estimate the relation between aggregate income change and infant mortality with the following framework: is a binary indicator taking the value 1 if child in country died in the first 12 months of life during year . is the natural logarithm of per capita GDP and is the error term. The and γ coefficients identify country-specific fixed effects and a country-specific cubic time trend, respectively. SEs are clustered at the country level; is the coefficient of interest, describing the relationship between aggregate income shocks and infant mortality. We estimate this semi-elasticity of infant mortality to aggregate income decline separately by country income level, as classified by the World Bank 2020 income groups, as well as overall. Low-income economies are defined by a gross national income (GNI) per capita of As a projection of the aggregate income shock in each country, we compare growth predictions for the same calendar period made before and then during the pandemic. Specifically, we use the IMF WEO 2020 growth rates projected in October 2019 and in October 2020. We define the difference between the two projections as the growth shortfall that is likely attributed to the pandemic and the ensuing economic crisis. Between October 2019 and October 2020, the IMF revised downwards the growth projections for all countries. The average shortfall for low-income and middle-income countries is 9.3%. The average projected shortfall in low-income countries, 5.9%, is less than half of the projected average shortfall in upper-middle-income countries, 12.5%. To calculate the number of excess infant deaths that were likely caused by the pandemic in each country, we multiply the projected growth shortfalls with the β coefficient from the regression specification above. We then multiply by the projected number of births in each country, taken from the United Nation’s World Population Prospects 2019. The total number of births are projected for the 5-year period 2015–2020 and we assume equal proportion of births for each year (the projections are available at population.un.org/wpp).

Patient and public involvement

The study presents analysis of secondary data. There was no patient and public involvement.

Results

Estimation of the GDP-mortality relationship

The regression coefficient estimates are presented in table 1. A 1% decrease in GDP per capita is associated with a 0.23 increase in infant mortality per 1000 children born in low-income and middle-income countries. These estimates vary substantially by income group. A 1% decrease in per capita GDP is associated with increases of 0.48, 0.24 and 0.16 in infant mortality per 1000 children born in low-income, lower-middle-income and upper-middle-income countries, respectively.
Table 1

Estimated relationship between aggregate income shocks and infant mortality rate per 1000 children, by World Bank country income groups

Low-income countriesLower-middle-income countriesUpper-middle-income countriesLow-income and middle-income countries
−47.85***−23.73***−16.08***−23.12***
(17.71)(5.50)(6.80)(9.38)

Overall number of observed births is 5 273 350. The table presents coefficient estimates from regressions of infant mortality log per capita GDP with time trends and country fixed effects. SEs are presented in parentheses. There are four income groupings for countries; the country income groups follow the World Bank classification for fiscal year 2021.

Source: authors’ estimation using data from Demographic and Health Surveys and World Development Indicators.

*P<0.10, **p<0.05, ***p<0.01.

Estimated relationship between aggregate income shocks and infant mortality rate per 1000 children, by World Bank country income groups Overall number of observed births is 5 273 350. The table presents coefficient estimates from regressions of infant mortality log per capita GDP with time trends and country fixed effects. SEs are presented in parentheses. There are four income groupings for countries; the country income groups follow the World Bank classification for fiscal year 2021. Source: authors’ estimation using data from Demographic and Health Surveys and World Development Indicators. *P<0.10, **p<0.05, ***p<0.01. Our estimate for the relationship between GDP and infant mortality is significantly lower than the estimate presented in the study by Baird et al, using the same specification.5 This previous analysis estimated that a 1% decrease in GDP per capita is associated with a 0.40 increase in infant mortality per 1000 children born in low-income and middle-income countries. Two things might drive this difference. First, we have a different composition of countries given that more DHS datasets are available. Our analysis includes 83 countries relative to 59 in the earlier paper. Second, resiliency to income shocks may have improved over time through increased household incomes and more developed health systems.

Projection of excess infant mortality in 2020

In table 2, we report the estimated excess infant mortality in 128 low-income and middle-income countries, along with 95% CI around the estimate. The results by income group and region presented in table 2 are aggregations of the country-level projections presented in online supplemental appendix table A2. In total, we estimate 267 208 (112 000–422 415) excess infant deaths in lower-income and middle-income countries due to the growth shortfall in 2020. Most of the excess mortality is estimated to occur in the 46 lower-middle-income countries, even though the income mortality semi-elasticity in low-income countries is almost twice the size of that in lower-middle-income countries. This is explained both by the fact that there are more countries and more populous countries in the lower-middle-income countries group and because the IMF projects larger growth shortfalls in that group. It is worth noting than more than a third of the excess infant mortality is projected to be in India (99 642). India has the highest number of annual births (24 238 000) as well as a particularly large projected economic shortfall of −17.3%. Because of this, South Asia is the region with the highest expected excess infant mortality, although there are only eight countries included in the analysis. Nigeria and China are a distant second and third with projected excess infant deaths of 11 904 and 10 835.
Table 2

Projected excess infant deaths with 95% CIs, by World Bank country income groups and regions

Estimate95% CICountries
Total267 208112 000 to 422 415128
By income group
 Low-income economies65 62818 013 to 113 24129
 Lower-middle-income economies158 63886 646 to 230 62846
 Upper-middle-income economies42 9427340 to 78 54453
By region
 Sub-Saharan Africa82 23929 198 to 135 28048
 East Asia and Pacific32 53712 899 to 52 17419
 Europe and Central Asia79622372 to 13 55320
 Latin America and the Caribbean17 2023628 to 30 77623
 Middle East and North Africa14 1274067 to 24 18710
 South Asia113 14159 836 to 166 4468

The definitions of income groups and regions are based on the World Bank country group categorisation for the 2021 fiscal year.

Source: authors’ projections based on estimated parameters presented in table 1 and data from International Monetary Fund World Economic Outlook and World Population Prospects.

Projected excess infant deaths with 95% CIs, by World Bank country income groups and regions The definitions of income groups and regions are based on the World Bank country group categorisation for the 2021 fiscal year. Source: authors’ projections based on estimated parameters presented in table 1 and data from International Monetary Fund World Economic Outlook and World Population Prospects. To benchmark our projections of excess infant deaths, we assess the percentage increase in infant mortality these additional deaths represent. To that end, we calculate the expected infant mortality in the absence of the pandemic for the 128 countries. According to the World Bank’s World Development Indicators, estimated infant mortality rates in low-income, lower-middle-income and upper-middle-income countries were 48, 37 and 11 deaths per 1000 live births, respectively in 2019. We multiply these rates by the annual number of births in each country to forecast a total of 3 953 466 deaths. Assuming that infant mortality rate in 2020 would have been similar to that in 2019 if the COVID-19 outbreak has not occurred, the excess deaths we project correspond to an increase of 6.8% (95% CI 2.8% to 10.7%) in the total number of expected infant deaths.

Discussion

In this study, we have assessed the potential impact of the 2020 economic downturn caused by the COVID-19 pandemic on infant mortality—we estimate almost 270 000 excess infant deaths in the 12 months following the start of the pandemic. A useful comparison point to this estimate is the 28 000–50 000 excess infant deaths estimated for Africa after the financial crisis in 2009.7 Our Africa estimate in 2020 is 82 239 (95% CI 37 858 to 126 620) infant deaths. This higher projection reflects the larger estimated GDP shortfalls. Several mechanisms are likely driving this increase in mortality among children 0–1 year of age: impoverishment at the household level will lead to worse nutrition and care practices for infants and reduced ability to access health services, while the economic crisis might also affect the supply and quality of services offered by the health systems.19 It is difficult to compare our estimates with other projections focusing on health system disruption as the main driver as the methodology, the age ranges and the time period are different. The most comparable study, with a focus on child mortality, predicts 253 500–1 157 000 additional under-5 child deaths over the first 6 months of the pandemic, depending on the scenario severity.15 Our estimates of excess infant mortality are not additional to previous projections but serve as an alternative. Our reduced form approach yields estimates that already incorporate at least some consequences of reduced utilisation of health services, that is, those reductions that have historically arose during severe economic downturns. Our estimates also directly account for other mechanisms, mainly increased poverty. As past economic crises were not driven by a pandemic, it is possible that the world will experience a higher indirect mortality shock than implied by the historic income-mortality semi-elasticity if the current economic downturn is accompanied by more severe disruptions to the supply of effective health services. Therefore, our projections may provide a lower bound of actual indirect mortality. On the other hand, the projections reported in this paper ascribe the difference between the WEO October 2019 and October 2020 economic growth projections for 2020 solely to the pandemic, even though some countries have also experienced other shocks, such as natural disasters or political crises. Regarding limitations of the analysis, one refinement of our estimation approach would consider the relevant expenditure categories that directly determine the production of child health, rather than overall expenditure as captured in GDP. Relevant expenditure categories include public health sector spending, private spending on health and nutrition, foreign assistance in the form of health aid and public and private spending on related sectors and services such as water and sanitation. It is these components of GDP that are more directly tied to child survival and would likely exhibit a more predictive relationship to infant mortality than overall GDP exhibits. Unfortunately, these more granular data do not exist in a systematic and standardised form for the countries and time periods considered, nor are there standard future projections of such components. Therefore, we follow the existent literature and explore the relation between a widespread summary measures of national economic output, GDP, and infant survival. An extension of our approach may also consider country characteristics that likely mediate the GDP-mortality relation, including measures of economic inequality. Infant mortality in more unequal countries is likely more vulnerable to economic contractions. However, here again, we do not have the necessary annual data to easily include a summary inequality measure such as the Gini coefficient within our estimation framework. The DHS allow us to construct annual birth and mortality indicators from retrospective reports of fertility yet do not include per capita consumption or wealth status for the same years. Standard cross-country datasets such as PovCalNet (iresearch.worldbank.org/PovcalNet/index.htm) update the national Gini coefficient only on a sporadic basis. For example, the Gini estimate for India is only updated for the years 1987, 1993, 2004, 2009, and 2011. Another limitation of our analysis is that it relies on retrospective birth histories in DHS. In the absence of comprehensive and robust vital registration statistics in most of the countries included in this analysis, this is likely the most comprehensive data source available. However, such household survey data can be affected by recall bias, especially for birth and deaths occurring long before the survey date. For this reason, we have explored the stability of estimates to alternative birth recall periods and find appreciably similar results. Another limitation is that we only consider the short-term impact of GDP fluctuations on mortality while long-term consequences might also exist. Long-term impacts on the number of infant deaths could also occur through changes in fertility behaviour but should not affect our projections for 2020. Although COVID-19 was first detected in the end of 2019, the outbreak was declared a pandemic only in March 2020. If there were impacts on fertility, they would impact births and infant mortality in 2021. Finally, economic contractions in high-income countries might reduce foreign aid to lower-income countries which in turn can increase mortality.24 If declining aid affects future GDP, our model does not account for such mechanisms as we assume that a country’s infant mortality rate is only affected by its (own) contemporaneous GDP. Regarding the reported CIs for projected excess infant deaths in table 2, note that these bounds may be regarded as conservative. This is because we first apply the 5th percentile lower bound and then the 95th percentile upper bound estimate of the mortality semi-elasticity to the projected growth contractions for all countries in order to estimate the bounds. This exercise implicitly imposes a perfect correlation of semi-elasticities across countries. If instead, each country receives its own independent draw from the distribution of semi-elasticities then there will be significantly tighter confidence bounds, at least in expectation. On the other hand, there may also be forecast error in either the country-level economic growth projections or in the projections of number of births. These potential errors are not directly modelled. Previous literature suggests these forecast errors have an expected mean of zero, with most deviations from forecast on the order of ±1 percentage point of economic growth or ±3% of total births.2526 To explore further the role of uncertainty in economic and demographic projections, we consider Monte Carlo simulations that model country-specific growth and birth projections with a slightly larger anticipated degree of error. Specifically, we simulate a draw for each country from growth projections that are uniformly distributed around the projection at ±1.5 percentage points and draws for the birth projection that are uniformly distributed around the projection at ±4%. After 10 000 simulations, we obtain a 95% CI of total excess deaths to be (251 588 to 283 106), substantially narrower than the reported CI of (112 000 to 422 415). This suggests that uncertainty in the true value of the growth-IMR semi-elasticity is the most influential parameter driving uncertainty in the projected total number of indirect infant deaths. Regardless of the exact number of projected deaths, the large number of excess infant deaths estimated in our analysis underscores the vulnerability of this age group to negative aggregate income shocks such as those induced by the COVID-19 pandemic. While we focused on the 0–1 age group, our estimates are suggestive of other vulnerabilities not directly attributable to COVID-19 among other segments of the population such as children aged 1–5 years, pregnant women and the elderly. As countries, health systems and the wider global community continue efforts to prevent and treat COVID-19, we should also consider resources to stabilise health systems and strengthen social safety nets in order to mitigate the human, social and economic consequences of the pandemic and related lockdown policies.
  16 in total

1.  Health Effects of Economic Crises.

Authors:  Christopher J Ruhm
Journal:  Health Econ       Date:  2016-11       Impact factor: 3.046

2.  Disruptions in maternal and child health service utilization during COVID-19: analysis from eight sub-Saharan African countries.

Authors:  Gil Shapira; Tashrik Ahmed; Salomé Henriette Paulette Drouard; Pablo Amor Fernandez; Eeshani Kandpal; Charles Nzelu; Chea Sanford Wesseh; Nur Ali Mohamud; Francis Smart; Charles Mwansambo; Martina L Baye; Mamatou Diabate; Sylvain Yuma; Munirat Ogunlayi; Rwema Jean De Dieu Rusatira; Tawab Hashemi; Petra Vergeer; Jed Friedman
Journal:  Health Policy Plan       Date:  2021-06-19       Impact factor: 3.344

3.  The potential public health consequences of COVID-19 on malaria in Africa.

Authors:  Ellie Sherrard-Smith; Alexandra B Hogan; Arran Hamlet; Oliver J Watson; Charlie Whittaker; Peter Winskill; Fatima Ali; Audu B Mohammad; Perpetua Uhomoibhi; Ibrahim Maikore; Nnenna Ogbulafor; Jamilu Nikau; Mara D Kont; Joseph D Challenger; Robert Verity; Ben Lambert; Matthew Cairns; Bhargavi Rao; Marc Baguelin; Lilith K Whittles; John A Lees; Sangeeta Bhatia; Edward S Knock; Lucy Okell; Hannah C Slater; Azra C Ghani; Patrick G T Walker; Okefu Oyale Okoko; Thomas S Churcher
Journal:  Nat Med       Date:  2020-08-07       Impact factor: 87.241

4.  Effects of economic downturns on child mortality: a global economic analysis, 1981-2010.

Authors:  Mahiben Maruthappu; Robert A Watson; Johnathan Watkins; Thomas Zeltner; Rosalind Raine; Rifat Atun
Journal:  BMJ Glob Health       Date:  2017-04-18

5.  Early estimates of the indirect effects of the COVID-19 pandemic on maternal and child mortality in low-income and middle-income countries: a modelling study.

Authors:  Timothy Roberton; Emily D Carter; Victoria B Chou; Angela R Stegmuller; Bianca D Jackson; Yvonne Tam; Talata Sawadogo-Lewis; Neff Walker
Journal:  Lancet Glob Health       Date:  2020-05-12       Impact factor: 26.763

6.  Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.

Authors:  Kaja Abbas; Simon R Procter; Kevin van Zandvoort; Andrew Clark; Sebastian Funk; Tewodaj Mengistu; Dan Hogan; Emily Dansereau; Mark Jit; Stefan Flasche
Journal:  Lancet Glob Health       Date:  2020-07-17       Impact factor: 26.763

Review 7.  The impact of the COVID-19 pandemic on maternal and perinatal health: a scoping review.

Authors:  Bethany Kotlar; Emily Gerson; Sophia Petrillo; Ana Langer; Henning Tiemeier
Journal:  Reprod Health       Date:  2021-01-18       Impact factor: 3.223

8.  Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.

Authors:  Andrew T Levin; William P Hanage; Nana Owusu-Boaitey; Kensington B Cochran; Seamus P Walsh; Gideon Meyerowitz-Katz
Journal:  Eur J Epidemiol       Date:  2020-12-08       Impact factor: 8.082

9.  Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study.

Authors:  Alexandra B Hogan; Britta L Jewell; Ellie Sherrard-Smith; Juan F Vesga; Oliver J Watson; Charles Whittaker; Arran Hamlet; Jennifer A Smith; Peter Winskill; Robert Verity; Marc Baguelin; John A Lees; Lilith K Whittles; Kylie E C Ainslie; Samir Bhatt; Adhiratha Boonyasiri; Nicholas F Brazeau; Lorenzo Cattarino; Laura V Cooper; Helen Coupland; Gina Cuomo-Dannenburg; Amy Dighe; Bimandra A Djaafara; Christl A Donnelly; Jeff W Eaton; Sabine L van Elsland; Richard G FitzJohn; Han Fu; Katy A M Gaythorpe; William Green; David J Haw; Sarah Hayes; Wes Hinsley; Natsuko Imai; Daniel J Laydon; Tara D Mangal; Thomas A Mellan; Swapnil Mishra; Gemma Nedjati-Gilani; Kris V Parag; Hayley A Thompson; H Juliette T Unwin; Michaela A C Vollmer; Caroline E Walters; Haowei Wang; Yuanrong Wang; Xiaoyue Xi; Neil M Ferguson; Lucy C Okell; Thomas S Churcher; Nimalan Arinaminpathy; Azra C Ghani; Patrick G T Walker; Timothy B Hallett
Journal:  Lancet Glob Health       Date:  2020-07-13       Impact factor: 26.763

10.  Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models.

Authors:  Britta L Jewell; Edinah Mudimu; John Stover; Debra Ten Brink; Andrew N Phillips; Jennifer A Smith; Rowan Martin-Hughes; Yu Teng; Robert Glaubius; Severin Guy Mahiane; Loveleen Bansi-Matharu; Isaac Taramusi; Newton Chagoma; Michelle Morrison; Meg Doherty; Kimberly Marsh; Anna Bershteyn; Timothy B Hallett; Sherrie L Kelly
Journal:  Lancet HIV       Date:  2020-08-06       Impact factor: 12.767

View more
  3 in total

1.  Parents' experiences regarding neonatal care during the COVID-19 pandemic: country-specific findings of a multinational survey.

Authors:  Johanna Kostenzer; Charlotte von Rosenstiel-Pulver; Julia Hoffmann; Aisling Walsh; Silke Mader; Luc J I Zimmermann
Journal:  BMJ Open       Date:  2022-04-07       Impact factor: 2.692

2.  A cross-country analysis of macroeconomic responses to COVID-19 pandemic using Twitter sentiments.

Authors:  Zahra Movahedi Nia; Ali Ahmadi; Nicola L Bragazzi; Woldegebriel Assefa Woldegerima; Bruce Mellado; Jianhong Wu; James Orbinski; Ali Asgary; Jude Dzevela Kong
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

3.  Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data.

Authors:  Tashrik Ahmed; Timothy Roberton; Petra Vergeer; Peter M Hansen; Michael A Peters; Anthony Adofo Ofosu; Charles Mwansambo; Charles Nzelu; Chea Sanford Wesseh; Francis Smart; Jean Patrick Alfred; Mamoutou Diabate; Martina Baye; Mohamed Lamine Yansane; Naod Wendrad; Nur Ali Mohamud; Paul Mbaka; Sylvain Yuma; Youssoupha Ndiaye; Husnia Sadat; Helal Uddin; Helen Kiarie; Raharison Tsihory; George Mwinnyaa; Jean de Dieu Rusatira; Pablo Amor Fernandez; Pierre Muhoza; Prativa Baral; Salomé Drouard; Tawab Hashemi; Jed Friedman; Gil Shapira
Journal:  PLoS Med       Date:  2022-08-30       Impact factor: 11.613

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.